Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics
Rima Nabbout, Joseph Sullivan, Stéphane Auvin, J. Helen Cross et autres
0 citationsEpilepsia Open
UCB Pharma (United States)
Atlanta · US · company
936Publications signalées
51040Citations signalées
12Thèmes principaux
Principaux domaines
Epilepsy research and treatmentPharmacological Effects and Toxicity StudiesSpondyloarthritis Studies and TreatmentsPsoriasis: Treatment and PathogenesisRheumatoid Arthritis Research and TherapiesNeuroscience and Neuropharmacology ResearchNeurological disorders and treatmentsInflammatory Bowel DiseaseParkinson's Disease Mechanisms and TreatmentsPharmaceutical studies and practicesMonoclonal and Polyclonal Antibodies ResearchSystemic Lupus Erythematosus Research
Évolution annuelle
Publications récentes
Changes in effectiveness and safety in patients with Lennox–Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open‐label extension study
Rima Nabbout, Orrin Devinsky, Lieven Lagae, Ingrid E. Scheffer et autres
0 citationsEpilepsia Open
Who Achieves Minimal and Very Low Disease Activity in Psoriatic Arthritis? An Analysis of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Alexis Ogdie, Chao Song, Nicole Middaugh, Maya Marchese et autres
0 citationsThe Journal of Rheumatology
Ribociclib in early breast cancer: interpreting the 4-year outcomes of the NATALEE trial
Prajakta P. Masurkar, Swarnali Goswami
0 citationsAME Clinical Trials Review
Pharmacokinetics, Effectiveness and Safety of Certolizumab Pegol in Children and Adolescents With Active Juvenile Idiopathic Arthritis: 9+‐Year Results From a Multicenter, Open‐Label Study
Hermine I. Brunner, Grebenkina La, Irina Nikishina, Ekaterina Alexeeva et autres
0 citationsArthritis & Rheumatology
At-home EEG-based sleep monitoring in people living with Lennox-Gastaut syndrome: The HEADFIRST study
Jay Pathmanathan, Franz Fürbass, Anna Marszalek, Sherry Ann Santarina et autres
0 citationsEpilepsy & Behavior
Characterization, healthcare resource utilization, and costs of health equity clusters of Medicaid‐insured patients with epilepsy: An exploratory machine learning approach
Herbert Peeples, Keshia Maughn, Christopher Dieyi, Emily Achter
0 citationsEpilepsy Research
Position Statement on Noninvasive Seizure Detection/Alerting Devices: A Joint Statement of the American Epilepsy Society, the Epilepsy Foundation, and the Danny Did Foundation
Caitlin L. Grzeskowiak, Sasha Alick-Lindstrom, Ausaf Bari, Mark Farrenburg et autres
0 citationsEpiliepsy currents/Epilepsy currents
Clinical Translation of Nanocarrier-based Drug Delivery Systems for the Treatment of Fatty Liver Disease
Pranav Shah, Priyanka Patil, Divya Gupta, Ruta Gupta et autres
0 citationsBENTHAM SCIENCE PUBLISHERS eBooks
Healthcare resource utilization and persistence in children and adults with Dravet syndrome receiving fenfluramine: a retrospective analysis using United States claims data
Wesley T. Kerr, Derek Ems, Srihari Jaganathan, Rob Sederman et autres
0 citationsSeizure
Advancing HIV Pre-Exposure Prophylaxis (PrEP) for Women: A Review of Ongoing Trials on Drug Development and Behavioral Interventions
Swarnali Goswami, P Masurkar, Chintal H. Shah, Samruddhi Nandkumar Borate
0 citationsCurrent Infectious Disease Reports
Mitragynine and 7-hydroxy-mitragyine plasma pharmacokinetics in humans after single and 15 multiple oral kratom extract doses
Marilyn A. Huestis, Martin A. Brett, John Bothmer, Jack E. Henningfield et autres
0 citationsJournal of Analytical Toxicology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.